Reimann I W, Britzelmeier C, Haber P, Wollmann H, Antonin K H, Bieck P R
Humanpharmakologisches Institut, CIBA-GEIGY, Tübingen, Federal Republic of Germany.
Eur J Clin Pharmacol. 1987;33(2):147-50. doi: 10.1007/BF00544558.
The specific binding (Bmax) of (3H-methyl)yohimbine to alpha 2-adrenoceptor binding sites on intact platelets was increased by 43% in 6 out of 7 young male volunteers 4 days after a single i.m. injection of 10 mg sustained release oestradiol, and it had returned to the starting value 4 weeks after drug administration. Mean plasma oestradiol was 331 pg/ml on Day 4 and it was within the pre-treatment control range of 19 pg/ml 4 weeks after the injection. A close correlation between the post-injection plasma oestradiol concentration and the increase in alpha 2-adrenoceptor binding sites on intact platelets was not found.
单次肌内注射10mg缓释雌二醇后4天,7名年轻男性志愿者中有6人的(3H-甲基)育亨宾与完整血小板上α2-肾上腺素能受体结合位点的特异性结合(Bmax)增加了43%,给药4周后其已恢复至起始值。第4天血浆雌二醇平均水平为331pg/ml,注射4周后其处于19pg/ml的治疗前对照范围内。未发现注射后血浆雌二醇浓度与完整血小板上α2-肾上腺素能受体结合位点增加之间存在密切相关性。